Stock Events

Stock Events

JSP 

$16.00
13
+$0.00+0% Tuesday 16:40

Statistics

Day High
14.72
Day Low
14.72
52W High
16
52W Low
14.72
Volume
800
Avg. Volume
4
Mkt Cap
502.61M
P/E Ratio
10.19
Dividend Yield
1.95%
Dividend
0.31

Upcoming

30
SEP
Dividend Ex
Decreased
 
4
DEC
Dividend Payment
Decreased
 
31
MAR 27
Dividend Ex
 
30
SEP 27
Dividend Ex
Estimated
 
3
DEC 27
Dividend Payment
Estimated
 

Dividends

1.95%Dividend Yield
Jun 26
$0.32
Dec 25
$0.27
Jun 25
$0.27
Dec 24
$0.28
Jun 24
$0.26
10Y Growth
4.1%
5Y Growth
6.87%
3Y Growth
20.88%
1Y Growth
16.75%

Earnings

5AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
5.8
38.71
71.62
104.54
Expected EPS
N/A
Actual EPS
N/A

Financials

4.73%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.17BRevenue
55.25MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow JSPCF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.38B
Pfizer Inc. is a global pharmaceutical corporation that competes with JSP in developing and marketing medications and vaccines for a wide range of medical disciplines.
Novartis
NVS
Mkt Cap292.07B
Novartis AG operates in the pharmaceuticals sector, offering products that directly compete with JSP's range of pharmaceutical and therapeutic solutions.
Merck
MRK
Mkt Cap294.03B
Merck & Co., Inc. is a leading healthcare company that competes with JSP in the pharmaceuticals sector, particularly in the development of innovative medicines and vaccines.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson is a diversified healthcare giant that competes across a broad range of sectors, including pharmaceuticals, medical devices, and consumer health products, overlapping with JSP's market.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie Inc. is a research-based biopharmaceutical company that competes with JSP in developing advanced therapies for complex diseases, particularly in immunology and oncology.
GSK
GSK
Mkt Cap106.31B
GlaxoSmithKline plc is a global healthcare company that competes with JSP in the pharmaceutical and healthcare products sector, with a focus on pharmaceuticals, vaccines, and consumer healthcare.
Sanofi
SNY
Mkt Cap105.92B
Sanofi is a global biopharmaceutical company focused on human health, directly competing with JSP in the areas of pharmaceuticals and vaccines.
Bristol-Myers Squibb
BMY
Mkt Cap116.66B
Bristol Myers Squibb is a global biopharmaceutical company that competes with JSP in the discovery, development, and delivery of innovative medicines that help patients prevail over serious diseases.
AMGEN
AMGN
Mkt Cap191.7B
Amgen Inc. is one of the world's leading biotechnology companies, competing with JSP in the development of biologic medicines for various therapeutic areas, including oncology, cardiovascular, and inflammatory diseases.

About

Globally, JSP Corporation specializes in the production and distribution of expanded polymers. Its product portfolio includes advanced material solutions like ARPRO, a highly effective impact energy absorption material. ARPRO finds widespread application in the automotive industry, durable transport packaging, and HVAC system components. Another key offering is STYRODIA, which serves diverse sectors from consumer electronics packaging and insulated food containers to building insulation and civil engineering projects. Additionally, FOAMCORE is utilized in the manufacturing of prefabricated bathroom units and various automotive parts. Beyond these, JSP manufactures a range of sheet and board products, marketed under trademarks such as MIRAMAT, CAPLON, P-BOARD, STYRENE PAPER, MIRABOARD, and MIRAFOAM. These products cater to industries including advertising displays, construction, and both food and industrial packaging. Established in 1962, JSP Corporation maintains its headquarters in Tokyo, Japan. The company operates as a subsidiary of Mitsubishi Gas Chemical Company, Inc.
Show more...
CEO
Mr. Tomohiko Okubo
Employees
3053
Country
United States
ISIN
JP3386000008

Listings

OTC Link
US
JSPCF
TSE
JP
7942.TSE

0 Comments

Share your thoughts

FAQ

What is JSP stock price today?▼
The current price of JSPCF is $16.00 USD — it has increased by +0% in the past 24 hours. Watch JSP stock price performance more closely on the chart.
What is JSP stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange JSP stocks are traded under the ticker JSPCF.
What is JSP market cap?▼
Today JSP has the market capitalization of 502.61M
When is the next JSP earnings date?▼
JSP is going to release the next earnings report on August 05, 2026.
What were JSP earnings last quarter?▼
JSPCF earnings for the last quarter are 0.23 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is JSP revenue for the last year?▼
JSP revenue for the last year amounts to 1.17B USD.
What is JSP net income for the last year?▼
JSPCF net income for the last year is 55.25M USD.
Does JSP pay dividends?▼
Yes, JSPCF dividends are paid semi-annual. The last dividend per share was 0.32 USD. As of today, Dividend Yield (FWD)% is 1.95%.
How many employees does JSP have?▼
As of June 17, 2026, the company has 3,053 employees.
In which sector is JSP located?▼
JSP operates in the Other sector.
When did JSP complete a stock split?▼
JSP has not had any recent stock splits.
Where is JSP headquartered?▼
JSP is headquartered in Tokyo, United States.